Monthly Archives: April 2010

Jury Upholds Pfizer Patent on Drug for Acid Reflux and Finds Infringement

The jury found on April 23 that Teva Pharmaceuticals USA Inc., Kudco Ireland Ltd. and Sun Pharma Global Inc. infringed on the patent when they filed applications with the Food and Drug Administration to sell generic versions of Protonix.

Leo Galland, M.D.: Acid Reflux: The Truth Behind Heartburn

Although certain drugs can be effective in relieving unpleasant symptoms of acid reflux, they don’t really deal with the underlying issue.

5 Foods That Sabotage Sleep

If you’re having trouble getting good sleep, you may need to look at your daily menu.

5 Foods That Sabotage Sleep

If you’re having trouble sleeping , what about a midnight snack? Think twice — here are five foods that can prevent you from getting a good night’s rest.

Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics

NORCROSS, Ga.—-Guided Therapeutics, Inc. today announced that Konica Minolta Opto, Inc. of Tokyo has extended its licensing agreement to co-develop non-invasive cancer detection products.

Patients should demand to see the science behind recommendation

Have you ever seen those TV commercials where some vaguely familiar character actor comes on wearing a white lab coat, with a stethoscope around the neck, and says: “I’m not a doctor, but I play one on television?”

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia …

Proton Pump Inhibitor DEXILANTTM (dexlansoprazole) Now Available In U.S. Pharmacies

Takeda Pharmaceuticals North America, Inc. today announced that DEXILANTâ„¢ (dexlansoprazole) delayed release capsules are now available in United States (U.S.) pharmacies. Takeda recently announced that the product trade name for dexlansoprazole in th…

Kosmas hears health care concerns

TITUSVILLE For Cocoa garden and landscape designer Linda Gombert, one slip on a wet lawn could mean an expensive medical bill that she would have to cover.

The tiny magnets that can cure your heartburn

The device is fitted around the bottom of the oesophagus – the ‘pipe’ through which food travels to the stomach.

Sing in the shower, sit up straight – the simple tips that’ll keep your voice young

As we get older, most of us worry about grey hair, wrinkles and maintaining a youthful physique. But many ignore one of the biggest signs of age – our voice.

Pfizer wins court battle over generic versions of Protonix

Pfizer can now ask the judge to order the generic drug makers to stop selling their versions of the medicine until the patent expires in January. A second trial would be held to determine what Pfizer should be paid for profit lost since Teva and Sun began selling cheaper versions of the drug two years ago.

Proton Pump Inhibitor DEXILANT(TM) (dexlansoprazole) Now Available in U.S. Pharmacies

DEERFIELD, Ill., April 26 /PRNewswire/ — Takeda Pharmaceuticals North America, Inc. today announced that DEXILANT(TM) (dexlansoprazole) delayed release capsules are now available in United States (U.S.) pharmacies.

Jury finds Protonix main patent not invalid, Sun Pharma to wait for final verdict

In an ongoing Para IV infringement litigation between the Wyeth (now part of Pfizer) and patent holder Nycomed against Indian drug major Sun Pharma and the Teva Pharmaceuticals USA over generic Protonix, an acid reflux drug, a jury in the US District Court for the District of New Jersey has returned a verdict that the main US patent for the product is not invalid.

Mini Medical series to begin Tuesday

The University at Buffalo’s Mini Medical spring series will begin this month with a theme focusing on medications and their actions.

Merck to help sell Nycomed lung drug in EU, Canada

Swiss drugmaker reiterates plans for IPO. 26 Apr 2010 7:21 PM

Non-invasive surgery introduced at Sutter Lakeside

LAKEPORT, Calif. A new non-invasive surgery procedure, or surgery without an incision, for those suffering from gastroesophegeal reflux disease (GERD) is now available from Keith Donald, M.D., general surgeon at Sutter Lakeside Hospital.

Pfizer wins Protonix patent case vs Teva

* Jury finds Protonix patent infringed by Teva

March of Dimes walk turns 40 this weekend

Lorna London Johnson’s three kids lead busy lives, as do most of their peers. She and her husband Darrin Johnson are deeply grateful for the life-saving care their daughters received after they came into the world in late May 2003, two months before they were due.

Linn town chairman resigns

Dave Bollweg is hanging his hat after serving more than 15 years as the Linn town chairman.